FILED UNDER SOMETHINGISRAELI >> Health & Lifestyle
Research
|
The Michael J Fox Foundation has given a grant of $490,000 to an Israeli company that is developing a special skin patch to help those who suffer from Parkinson's disease.
NeuroDerm, based in Ofakim was established in 2002 with the objective of providing a way to provide continuous delivery of levodopa which acts as a way to help Parkinson’s patients create dopamine in their body which combats the disease.
"We are delighted that the Foundation has recognized the immense impact our program may have on the lives of many Parkinson's patients," said Eli Heldman, PhD and Moshe Kushnir, MD, founders of NeuroDerm. "We hope that NeuroDerm will be able to offer a practical solution to patients suffering from damage caused in late-stage Parkinson's disease and to earlier stage patients wishing to slow down the development of late motor complications"
"This Clinical Discovery Program grant is part of our focus on speeding highly relevant treatments to people living with Parkinson's disease," said Deborah W Brooks, president and CEO of The Michael J. Fox Foundation. "We believe that improved delivery through continuous levodopa administration, such as NeuroDerm's prospective patch aims to achieve, could potentially result in a significant improvement in patients' day-to-day lives."
For more information: www.neuroderm.co.il